[Parkinson's disease: neuro-anatomical, biochemical and pharmicotherapeutic aspects].
D001479:Basal Ganglia / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism; D006719:Homovanillic Acid / Q000134:cerebrospinal fluid; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000134:cerebrospinal fluid; D007980:Levodopa / Q000627:therapeutic use*; D008875:Middle Aged; D018377:Neurotransmitter Agents / Q000378:metabolism*; D010300:Parkinson Disease / Q000188:drug therapy / Q000378:metabolism / Q000503:physiopathology
D018377:Neurotransmitter Agents; D007980:Levodopa; D006897:Hydroxyindoleacetic Acid; D004298:Dopamine; D006719:Homovanillic Acid
Ziekte van Parkinson: neuroanatomische, biochemische en farmacotherapeutische aspecten